Orchid Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma Limited submitted to the exchanges a compliance certificate under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. The certificate, issued by their Registrar and Share Transfer Agent (RTA) M/s Abhipra Capital Limited, covers Quarter I of FY 2025-26 ended June 30, 2025. It confirms that securities received from depository participants for dematerialization were processed and reported back to the depositories during the quarter. It also confirms that dematerialized share certificates were mutilated and cancelled, and that the depository's name was substituted as the registered owner in the company's register of members within the 15-day deadline. The certificate was signed by Abhinav Aggarwal, Director of Abhipra Capital, on July 8, 2025.
This is a routine quarterly regulatory compliance filing with no material business or price impact. It simply confirms that Orchid Pharma's RTA properly handled share dematerialization activities during Q1 FY26, indicating sound back-office governance.